Flu Vaccine business is barely profitable. Took until 2018 to turn a profit. Sales of over $1 billion for a $50 million profit. That was less than 5% margins. Not to mention years of accumulated losses. In any event, it is literally chicken feed.
On the CSL 112 front, that hype has already been factored into the price. Why do you think CSL stock is over $300? All that R&D blue sky is baked into the price. How else can you justify a PE of 50 and a market cap of circa $150 billion????? Based on its plasma business it can only generate single digit growth now of 8%. That hardly justifies multiples of 50 times current earnings!!!
Flu Vaccine business is barely profitable. Took until 2018 to...
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$272.17 |
Change
-4.840(1.75%) |
Mkt cap ! $131.3B | |||
| Open | High | Low | Value | Volume |
| $271.21 | $272.90 | $270.09 | $104.9M | 384.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 96 | $272.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $272.18 | 4 | 2 |
View Market Depth
| Last trade - 13.30pm 18/11/2024 (20 minute delay) ? |
| CSL (ASX) Chart |